Cart
sales@molnova.com
GSK-1520489A
CAS No. 1042433-41-9
GSK-1520489A( —— )
Catalog No. M28990 CAS No. 1042433-41-9
GSK-1520489A is an active PKMYT1 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 121 | In Stock |
|
| 10MG | 188 | In Stock |
|
| 25MG | 335 | In Stock |
|
| 50MG | 460 | In Stock |
|
| 100MG | 647 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGSK-1520489A
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK-1520489A is an active PKMYT1 inhibitor.
-
DescriptionGSK-1520489A is an active PKMYT1 inhibitor.
-
In VitroGSK-1520489A (4 μM, 24 h) treatment shows inhibition of phosphorylation of Tyr15 in Cdk1. Western Blot Analysis Cell Line:HT29 cells Concentration:4 μM Incubation Time:24 hours Result:Reduced Cdk1-phosphorylation at tyrosine in comparison to the uninhibited reaction.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorMCT4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1042433-41-9
-
Formula Weight538.53
-
Molecular FormulaC21H23N4O7PS2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 35.71 mg/mL (83.92 mM)
-
SMILESCC(C)(C)S(c1cc2c(Nc(cc3)cc4c3scn4)ncnc2cc1OCCOP(O)(O)=O)(=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cluntun AA, et.al. The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure. Cell Metab. 2021 Mar 2;33(3):629-648.e10.
molnova catalog
related products
-
TB5
TB5 is a potent, selective and reversible inhibitor of hMAO-B.
-
Squalane
Squalane is a naturally occurring lipid in both plants and animals. It is usually used as a moisturizer and emollient in cosmetics manufacturing.
-
Metastin (human)
Potent endogenous ligand of the kisspeptin receptor (KISS1, GPR54). Binds with high affinity to rat and human KISS1 receptors with Ki values of 1.80 and 1.45 nM respectively. Inhibits chemotaxis, invasion and metastasis of human melanomas and breast carcinomas. Stimulates gonadotropin secretion following i.c.v. administration.
